According to Bloomberg.com, the stock of Cross Country Healthcare, Inc. (NASDAQ: CCRN), which six different brokerages are presently covering, has been given an average rating of “Moderate Buy” by these brokerages. Three market watchers think the stock should be acquired, while the remaining three think it should be retained. The average price estimate for the next 12 months that analysts who have written reports on the stock in the past year have established for it is $35.20.
Several experts specializing in equity analysis have offered their opinions regarding the company. Barrington Research increased its target price on Cross Country Healthcare from $41.00 to $45.00 and gave the stock an “outperform” rating in a research report published on Monday, November 7th. Benchmark increased its price target on Cross Country Healthcare from $37.00 to $42.00 and gave the company a “buy” rating in a report released on Thursday, September 15th. The “buy” rating assigned to Cross Country Healthcare by Truist Financial was changed to a “hold” rating, and the price target for the company’s stock was lowered to $36.00 in a report published on Wednesday, October 5th. They explained that the choice was made after conducting an evaluation. On Wednesday, October 12th, StockNews.com expanded its coverage to include Cross Country Healthcare. They recommended that investors “hold on” to the shares.
On September 19th, William J. Burns, the company’s Chief Financial Officer, sold 14,705 shares of the company’s stock. At an average price of $28.99 per share, the stock was able to bring in a total of $426,297.95 when it was finally sold. Because of the transaction, the firm’s chief financial officer now owns 246,404 shares of the company’s stock, which have a value of $7,143,251.96. This information about the transaction was submitted to the Securities and Exchange Commission in the form of a filing, which can be found by following this link. In related news regarding Cross Country Healthcare, Chief Financial Officer William J. Burns disposed of 14,705 shares of the company’s stock on Monday, September 19th. At an average price of $28.99 per share, the stock was able to bring in a total of $426,297.95 when it was finally sold. Because of the transaction, the firm’s chief financial officer now owns 246,404 shares of the company’s stock, which have a value of $7,143,251.96. This information about the transaction was included in a filing with the SEC, which can be accessed here. In addition, on September 19th, the General Counsel for Cross Country Healthcare, Susan E. Ball, sold 44,357 shares of the company’s stock. At an average selling price of $28.99 per share, a total of $1,285,909.43 was realized from the stock sale. The general counsel currently owns 170,797 firm shares, which have a value of about 4,951,405.03 dollars. The disclosure for this sale can be found at this location. In the past ninety days, corporate insiders have sold 114,256 company stock for a total value of $3,404,694. Corporate insiders own five percent of the company’s equity.
Institutional investors have recently been active in the market, buying and selling the stock. KBC Group NV invested in Cross Country Healthcare in the amount of $65,000 during the second quarter. The percentage of ownership in Cross Country Healthcare held by Russell Investments Group Ltd. grew by 14.4% during the second quarter. Following the acquisition of 7,909 additional shares during the period, Russell Investments Group Ltd. now holds 62,782 shares of the company’s stock, which has a value of $1,307,000. First Eagle Investment Management LLC’s holdings in Cross Country Healthcare saw a 70.1% growth during the first quarter due to the company’s investment. First Eagle Investment Management LLC now owns 53,629 shares of the business services provider’s stock valued at $1,162,000 after purchasing an additional 22,092 shares during the most recent quarter. These shares were purchased during the third quarter. In addition, Islay Capital Management LLC boosted the percentage of ownership it holds in Cross Country Healthcare by 42.1% during the second quarter. Islay Capital Management LLC now has 10,054 shares of the business services provider’s stock, valued at $209,000 after the acquisition of an additional 2,978 shares during the most recent quarter.
Last but not least, Systematic Financial Management LP added 3.8% to the position it already held in Cross Country Healthcare during the first three months of the year. After purchasing 78,121 shares in the preceding quarter, Systematic Financial Management LP owns 2,118,199 shares of the business services provider’s stock. The current market value of these shares is $45,901,000. The company’s stock is owned by institutional investors and hedge funds to 95.25 percent.
The NASDAQ CCRN started the trading day on Thursday at $35.21. Cross Country Healthcare’s lowest price in the past year is $15.26, and its highest price in the past year is $40.12. The ratio of debt to equity is 0.31; the ratio of current assets to equity is 2.38, and the ratio of quick assets to equity is also 2.38. The moving average for the company over the past fifty days is $32.75, while the moving average over the last two hundred days is $25.77. The stock trades at a price-to-earnings ratio of 5.84, a price-to-earnings-to-growth ratio of 1.14, and a beta value of 1.00. The company’s market capitalization is $1.31 billion.
In the healthcare industry in the United States, clients of Cross Country Healthcare, Inc. benefit from talent management and other consulting services provided by the company. Nurse and Allied Staffing and Physician Staffing are the two branches that the organization operates under. The Nurse and Allied Staffing segment provides traditional staffing services. These services include the temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; per diem and short-term staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals; and long-term contract assignments for clinical and non-clinical professionals.